Naloxone saves lives. Communities providing access to naloxone have shown significant reductions in emergency department visits for opioid-related breathing emergencies. To realize the full potential of this harm-reduction intervention, we must do more to educate the public. Join this session to help your community by learning about the available naloxone delivery devices and their dispensing logistics.
At the completion of this knowledge-based activity, participants will be able to:
- Identify patients at risk of opioid-induced respiratory depression and recommend harm-reduction strategies for people who use unregulated substances.
- Distinguish among the different naloxone formulations and help patients and caregivers understand how and when to use them safely and effectively.
- Illustrate pharmacist communication strategies to break down barriers to naloxone distribution and increase acceptance of naloxone dispensing in the community.
- Demonstrate how to properly use and educate the layperson on naloxone formulations and use in an opioid-induced breathing emergency.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.25 contact hour of CPE credit (0.125 CEU). The ACPE Universal Activity Number for this activity is 0202-0000-21-049-H08-P
To obtain credit for End an Epidemic with Education: All You Need to Know About Naloxone, participants are required to watch the archived webinar, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.Initial release date: March 11, 2021
Expiration date: March 11, 2024 - No credit granted after this date
End an Epidemic with Education: All You Need to Know About Naloxone is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA Symposium on Substance Use Disorder and Patient Well-Being: Exploring the Mental Health Conditions Associated With Substance Use Disorders Package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.